Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) saw a large decrease in short interest in April. As of April 30th, there was short interest totaling 53 shares, a decrease of 94.6% from the April 15th total of 989 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 947 shares, the days-to-cover ratio is currently 0.1 days.
Institutional Investors Weigh In On Gyrodyne
Several hedge funds and other institutional investors have recently made changes to their positions in GYRO. Advisory Services Network LLC acquired a new position in Gyrodyne during the 3rd quarter valued at about $77,000. Susquehanna International Group LLP bought a new stake in shares of Gyrodyne in the 3rd quarter worth $142,000. Teton Advisors LLC purchased a new stake in shares of Gyrodyne in the third quarter valued at about $177,000. Finally, Bulldog Investors LLP purchased a new position in Gyrodyne during the third quarter worth about $601,000. 71.36% of the stock is owned by institutional investors.
Gyrodyne Trading Up 2.0%
Gyrodyne stock traded up $0.15 during mid-day trading on Tuesday, reaching $7.63. The stock had a trading volume of 451 shares, compared to its average volume of 1,096. Gyrodyne has a fifty-two week low of $6.70 and a fifty-two week high of $12.00. The stock’s 50-day simple moving average is $7.96 and its 200-day simple moving average is $8.80.
About Gyrodyne
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
See Also
- Five stocks we like better than Gyrodyne
- Shake Shack Stock Gets Shaken After Earnings Miss
- On Holdings Sets Up for Marathon Rally: New Highs Are Coming
- The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000
- MP Materials Is Quietly Building a Rare Earth Powerhouse
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
